Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
This trial is active, not recruiting.
|Sponsor||Medtronic Neurovascular Clinical Affairs|
|Start date||August 2014|
|End date||December 2017|
|Trial size||1000 participants|
|Trial identifier||NCT02239640, NV-SFR005|
The purpose of this registry is to assess outcomes associated with the use of devices intended to restore blood flow in patients experiencing acute ischemic stroke.
|United States||No locations recruiting|
|Other Countries||No locations recruiting|
Status of revascularization at the end of the interventional procedure
time frame: Day 0
Symptomatic intracranial hemorrhage
time frame: 90 days
Male or female participants of any age.
Inclusion Criteria: - An informed consent or waiver - Patient has experienced an acute ischemic stroke - Treatment within 8 hours of stroke onset Exclusion Criteria: - Concurrent participation in a randomized study
|Official title||Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry|
|Principal investigator||Nils Mueller-Kronast, M.D.|
|Description||This is a registry evaluating the use of devices in patients diagnosed with an acute ischemic stroke. This registry may enroll up to 1000 patients.|
Call for more information